| Literature DB >> 31579902 |
Marwa I Abd El-Hamid1, Naglaa F S Awad2, Yousreya M Hashem3, Mahmoud A Abdel-Rahman4, Adel M Abdelaziz5, Imad A A Mohammed2, Usama H Abo-Shama6.
Abstract
Among many avian mycoplasmas, Mycoplasma gallisepticum (MG) and Mycoplasma synoviae (MS) are recognized as the main etiological agents of respiratory diseases and infectious synovitis in chickens and turkeys causing tremendous economic losses worldwide. Therefore, proper treatment is promoted for the control of these diseases. This study was the first in Egypt to evaluate the in vitro efficacy of various antimicrobials against field MG and MS isolates recovered from chicken and turkey flocks using both conventional broth microdilution and quantitative real-time polymerase chain reaction assays. Totally, 47 mycoplasma isolates were recovered from 160 collected tracheal samples (29.4%). Of these, 44 MG (27.5%) and 3 MS (1.9%) were identified using conventional and molecular assays. The in vitro susceptibilities of 4 representative mycoplasma field isolates (3 MG and one MS) to 8 antibiotics and 4 essential oils were investigated. The tested isolates showed various susceptibilities to tested antimicrobials. Toldin CRD, followed by clove, cumin, and cinnamon oils were effective against both MG and MS clinical isolates with minimum inhibitory concentration (MIC) values ranging from 0.49 to 15.63 µg/mL. Similarly, tylvalosin was the most active antibiotic against MG and MS isolates with the lowest MIC values (0.015 to 0.03 µg/mL). DNA loads of both MG mgc2 and MS vlhA genes were markedly decreased upon treatment with majority of the tested antimicrobials confirming their effectiveness as was also evaluated by conventional MIC results. In conclusion, Toldin CRD and tylvalosin were found to be the most effective antimicrobials in this study. This finding highlights the importance of using these antimicrobials in controlling mycoplasma infections in chickens and turkeys.Entities:
Keywords: zzm321990 Mycoplasma species; broth microdilution qRT-PCR; toldin CRD; tylvalosin
Mesh:
Substances:
Year: 2019 PMID: 31579902 PMCID: PMC8913763 DOI: 10.3382/ps/pez576
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Prevalence and characterization of avian M. gallisepticum and M. synoviae in 4 flocks from different localities
| Biochemical characterization | Serological and molecular identification | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Flock No. | Host | Locality | No. of tracheal swabs | No. of positive mycoplasma isolates (%) | Glucose fermentation | Arginine deamination | Film and spot formation | No. of MG isolates (%) | No. of MS isolates (%) |
| 1 | Chicken | Faiyum | 50 | 3 (6) | + | – | + | 0 | 3 (6) |
| 2 | Giza | 50 | 25 (50) | + | – | – | 25 (50) | 0 | |
| 3 | Sharkia | 50 | 16 (32) | + | – | – | 16 (32) | 0 | |
| 4 | Turkey | El-Dakhleya | 10 | 3 (30) | + | – | – | 3 (30) | 0 |
| Total | 160 | 47 (29.4) | 44 (27.5) | 3 (1.9) | |||||
MG: Mycoplasma gallisepticum, MS: Mycoplasma synoviae.
In vitro antimicrobial activities of 4 essential oils against M. gallisepticum and M. synoviae isolates as determined by conventional broth microdilution and qRT-PCR methods
| Strain ID or median MIC value | MIC values of essential oils (μg/mL) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clove | Cinnamon | Cumin | Toldin CRD | |||||||||||
| Conventional | Conventional | Conventional | Conventional | |||||||||||
| Host | Locality | I | F | qRT-PCR | I | F | qRT-PCR | I | F | qRT-PCR | I | F | qRT-PCR | |
| MG1 | Chicken | Giza | 0.49 | 0.49 | 0.49 | 3.91 | 7.81 | 3.91 | 1.95 | 0.98 | 0.98 | 0.98 | 0.49 | 0.98 |
| MG2 | Chicken | Sharkia | 0.98 | 0.49 | 0.98 | 7.81 | 1.95 | 3.91 | 0.98 | 0.98 | 0.98 | 0.49 | 0.49 | 0.49 |
| MG3 | Turkey | El Dakhleya | 0.98 | 0.49 | 0.49 | 15.63 | 0.98 | 7.81 | 3.91 | 1.95 | 3.91 | 0.98 | 0.98 | 0.49 |
| MS | Chicken | Faiyum | 1.95 | 0.98 | 3.91 | 1.95 | 0.98 | 1.95 | 0.98 | 0.98 | 0.49 | 0.49 | 0.49 | 0.49 |
| Median MIC value | – | – | 0.98 | 0.74 | 5.86 | 3.91 | 1.47 | 0.98 | 0.74 | 0.49 | ||||
MG: Mycoplasma gallisepticum, MS: Mycoplasma synoviae, MIC: minimum inhibitory concentration, I: initial (profile), F: final, qRT-PCR: quantitative real time PCR.
Summary of initial and final MIC ranges (μg/mL) of the isolated M. gallisepticum and M. synoviae isolates with the suggested non-official breakpoints
| Antibiotic class | Antibiotic agent | Non-official breakpoints (Kreizinger et al., | Initial MIC range | Final MIC range |
|---|---|---|---|---|
| Macrolides | Tylvalosin | S ≤ 0.5; R > 2 | 0.015 to 0.03 | 0.015 to 0.125 |
| Tilmicosin | S ≤ 8; R ≥ 32 | 0.06 to 0.25 | 0.25 to 0.50 | |
| Tylosin | S ≤ 1; R ≥ 4 | 0.06 | 0.06 to 0.25 | |
| Fluoroquinolones | Enrofloxacin | S ≤ 0.5; R ≥ 2 | 0.25 to 2 | 1 to 2 |
| Tetracyclines | Doxycycline | S ≤ 4; R ≥ 16 | 0.125 to 0.5 | 0.25 to 1 |
| Chlortetracycline | S ≤ 4; R ≥ 16 | 0.5 to 16 | 2 to 16 | |
| Lincosamide | Lincomycin | S ≤ 2; R ≥ 8 | 0.25 to 2 | 2 to 8 |
| Pleuromutilins | Tiamulin | S ≤ 8; R ≥ 16 | 0.06 to 0.5 | 0.5 |
S: susceptible, R: resistant.
Comparison between MICs of various antibiotics for M. gallisepticum and M. synoviae isolates as determined by conventional broth microdilution and qRT-PCR methods with their corresponding susceptibility patterns.
| Strain ID or Median MIC value | MIC values (μg/mL) | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TVN | TIL | TYL | EFX | DX | CTC | LCM | TIA | |||||||||||||||||
| Conventional | qRT-PCR | Conventional | qRT-PCR | Conventional | qRT-PCR | Conventional | qRT-PCR | Conventional | qRT-PCR | Conventional | qRT-PCR | Conventional | qRT-PCR | Conventional | qRT-PCR | |||||||||
| I | F | I | F | I | F | I | F | I | F | I | F | I | F | I | F | |||||||||
| MG1 | 0.015 (S) | 0.125 | 0.031 | 0.125 (S) | 0.25 | 0.5 | 0.06 (S) | 0.25 | 0.125 | 0.25 (S) | 1 | 0.5 | 0.125 (S) | 1 | 0.25 | 0.5 (S) | 4 | 4 | 0.25 (S) | 2 | 0.25 | 0.125 (S) | 0.5 | 0.25 |
| MG2 | 0.031 (S) | 0.125 | 0.031 | 0.06 (S) | 0.5 | 0.5 | 0.06 (S) | 0.25 | 0.25 | 0.5 (S) | 2 (R) | 0.5 | 0.5 (S) | 1 | 0.5 | 16 (R) | 16 | 16 | 2 (S) | 8 (R) | 1 | 0.06 (S) | 0.5 | 0.5 |
| MG3 | 0.015 (S) | 0.015 | 0.062 | 0.25 (S) | 0.25 | 0.25 | 0.06 (S) | 0.06 | 0.125 | 2 (R) | 2 | 1 | 0.125 (S) | 0.25 | 0.125 | 1 (S) | 2 | 1 | 1 (S) | 2 | 2 | 0.25 (S) | 0.5 | 0.125 |
| MS | 0.015 (S) | 0.015 | 0.062 | 0.25 (S) | 0.25 | 0.5 | 0.06 (S) | 0.06 | 0.06 | 0.5 (S) | 2 (R) | 0.5 | 0.25 (S) | 1 | 0.25 | 2 (S) | 4 | 4 | 2 (S) | 8 (R) | 2 | 0.5 (S) | 0.5 | 0.5 |
| Median MIC value | 0.02 | 0.05 | 0.19 | 0.5 | 0.06 | 0.13 | 0.5 | 0.5 | 0.19 | 0.25 | 1.5 | 4 | 1.5 | 1.5 | 0.19 | 0.38 | ||||||||
MG: Mycoplasma gallisepticum, MS: Mycoplasma synoviae, MIC: Minimum inhibitory concentration, TVN: Tylvalosin, TIL: Tilmicosin, TYL: Tylosin, EFX: Enrofloxacin, DX: Doxycycline, CTC: Chlortetracycline, LCM: Lincomycin, TIA: Tiamulin, I: initial (profile), F: final, qRT-PCR: quantitative real time PCR.
Final MIC profiles differing from the initial ones, S: susceptible, R: resistant.
Figure 1Growth inhibition rates of MG1 (A), MG2 (B), MG3 (C), and MS (D) grown into mycoplasma medium with various concentrations of tylvalosin at 2, 4, 7, and 14 d post incubation.